Live News Categoriesmarket

RPRX.O (RPRX.O) News

Follow RPRX.O (RPRX.O) news in one place: company catalysts, earnings, analyst actions and wider market developments. Review 1 public stories across 1 publication days to understand how the story developed. Public news appears after a 15-minute delay; LiveCast subscribers can follow new headlines and hear important updates without this additional delay.

Symbol RPRX.O Asset market Sector Markets 90 days 1 Updated Oct 15, 2026, 05:22 PM UTC Open live news feed

L ANALYSIS — Revolution Medicines' Europe efforts signal solo launch ambitions for cancer drug European Commission review to follow after EMA panel backing RevMed gears up hiring in Europe, LinkedIn postings show Analysts say company can pursue ex-US launch alone By Sriparna Roy and Bhanvi Satija Oct 15 (Reuters) EARNINGS | Oct 15, 2026, 05:22 PM UTC